Archive - February 2019
Alunbrig recommended by NICE for non-small-cell lung cancer
Trajenta meets primary endpoint in CAROLINA trial
Could AI predict survival of ovarian cancer patients?
NICE changes its mind on Perjeta
Biosimilar Herceptin helps Roche gain new Perjeta recommendation
New Academy launched to fight osteoporosis
New asthma pill to target airway muscles
Diet Tips To Ease PMS Symptoms